Palisade Capital Management

mobile
news-insights-top

News & Insight

At Palisade Capital Management, we think differently than other asset managers. We believe in sharing ideas and research across teams—and now with you. Here you can gain access to our vast intellectual capital and decidedly different perspective, while seeing what we’ve been up to lately.



Monday, August 25, 2008
PCEPII Commits to Invest $3 Million in Caliber Therapeutics, Inc.
Posted in Announcements
On August 25, 2008, Palisade Concentrated Equity Partnership II, LP ("PCEPII"), a $140 million private equity fund managed by Palisade Capital Management, LLC, committed to invest $3 million in Caliber Therapeutics, Inc. ("Caliber"). Caliber is a provider of a potentially game-changing drug-eluding balloon technology for vascular applications. PCEPII committed to two separate tranches and invested $1.35 million in the first tranche of the $9 million Series A financing round. These funds will be used to secure and develop intellectual property, pay joint venture development costs, and prepare for clinical studies.
Friday, May 16, 2008
PCEPII invested $15 million in Glenmount Global Solutions, Inc.
Posted in Announcements
On May 16, 2008, PCEPII invests $15.0 million in Glenmount Global Solutions, Inc. ('Glenmount' or the 'Company'). Glenmount is a leading independent industrial IT services firm in North America, with over 350 associates in 25 offices. Proceeds from the financing round were used primarily to acquire Crown Holdings, which will be merged with Glenmount's two other operating companies to expand the Company's reach and expertise across a variety of industries and business sectors, including water & wastewater, metals, food & beverage, and oil & gas.
Monday, April 28, 2008
Eva Madha Joins Palisade Capital as Marketing Associate
Posted in Announcements
Ms. Madha joined Palisade Capital on April 28, 2008. As Marketing Associate, Eva is responsible for completing RFPs and for developing, preparing, revising and maintaining marketing materials, competitive analyses and lead generation. In addition, Eva will work with consultants to ensure that information regarding Palisade in consultants' databases is kept current. Eva joins us from Bear Stearns where she was a Marketing and Data Analyst. Prior to that, Eva worked for eight years at Merrill Lynch, her last position being Request for Proposal Analyst. Eva has successfully completed Level 1 of the CFA Program. She received her Aerospace Engineering Masters from Parks College, Cahokia, IL and her B.S. in Aerospace Engineering Technology from Cal State Polytechnic, Pomona, CA.
Monday, February 11, 2008
PCEPII Closes $6.2 Million Investment in Ruby Tequila’s Mexican Kitchen, LLC
Posted in Announcements
On February 11, 2008, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $6.2 million in Ruby Tequila's Mexican Kitchen, LLC ('Ruby Tequila's'). Ruby Tequila's operates four Texas Mexican style restaurants in Lubbock, Amarillo and Selma, Texas. Ruby Tequila's will use the financing to support its roll out of over 30 restaurants over the next five years. Ruby Tequila's was founded in 1991 and differentiates itself through the delivery of high quality mesquite grilled food made from scratch, good service, and a fun, vibrant atmosphere.
Friday, December 28, 2007
PCEPII Closes $8.1 Million Investment in Shoe Sensation, Inc.
Posted in Announcements
On December 28, 2007, Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $8.1 million in Shoe Sensation, Inc. ('Shoe Sensation'), a retailer of branded family footwear in small towns throughout the Midwest. Palisade intends to enhance Shoe Sensation's footprint across the rural Midwest as it grows into a leading niche purveyor of branded footwear and apparel.
Monday, December 03, 2007
PCEPII Closes $2.0 Million Investment in Mitralign, Inc.
Posted in Announcements
On December 3, 2007 Palisade Concentrated Equity Partnership II, LP, a $140 million private equity fund managed by Palisade Capital Management, LLC, invested $2.0 million in Mitralign, Inc. ("Mitralign") as part of a $24.0 million Series C financing round. Mitralign has developed an advanced system for treating mitral valve regurgitation, a heart condition which can lead to damage to the heart and other vital organs of the body. Proceeds from the financing round will enable Mitralign to complete its initial clinical experience and to obtain CE Mark approval of the Mitralign System.
‹ First  < 16 17 18 19 > 
Latest Research and White Papers
Wednesday, June 12, 2019
Small Cap Equities and the Case for Core
The composition of the small cap growth and value benchmarks within small cap equities has evolved and created an often-overlooked pitfall – the potential for unwanted industry concentration and portfolio exposures. Palisade believes that active small cap core equity investing represents a better solution. For the detailed analysis, please download our latest white paper.

Download the White Paper

For further information regarding this white paper or about Palisade Capital Management, please contact us at info@palcap.com.
Find Out More and Request This White Paper

See all Research and White Papers



Select A Category

Connect with Us

One Bridge Plaza, Suite 695, Fort Lee, New Jersey 07024 | (201) 585-7733 | Get Directions | Contact Us

Stay Informed

Sign up for our mailing list and stay up to date on the latest information and news from Palisade Capital Management.